A small-scale or micro media-mill and a method of milling materials or products, especially pharmaceutical products, use a dispersion containing attrition milling media and the product to be milled. The milling media can be polymeric, formed of polystyrene or cross-linked polystyrene, having a nominal diameter of no greater than 500 microns. Other sizes include 200 microns and 50 microns and a mixture of these sizes. The mill has a relatively small vessel having an opening, an agitator, a coupling, and a motor. The agitator can have a rotor and a shaft extending therefrom. The rotor can be cylindrical or have other configurations, and can have tapered end surfaces. The coupling can close the vessel opening, or attaching the coupling to the motor can close the opening. The coupling has an opening through which the rotor shaft extends into the motor. A sealing mechanism, such as a mechanical or lip seals the shaft while permitting the rotor shaft to rotate. The vessel can contain one or more ports for circulating the dispersion, where milling can be made in batches or recirculated through the milling chamber. The media can be retained in the vessel or recirculated along with the process fluid. The rotor is dimensioned so that its outer periphery is spaced with a small gap from an inner surface of the vessel. The vessel also can have a way of cooling the dispersion.
|
1. A small-scale mill for milling a non-soluble product contained in a dispersion containing attrition milling media, comprising:
a shaft mount; a rotatable shaft mounted for rotation about the shaft mount; a relatively small vessel having an opening; an agitator having a rotor and a rotor shaft extending from the rotor, the shaft being connected to the rotatable shaft and the rotor being dimensioned to be inserted in the vessel with a small gap formed between an outer rotating surface of the rotor and an internal surface of the vessel; a coupling detachably connecting the vessel to the shaft mount, the coupling having an opening through which the rotor shaft extends, wherein the shaft mount sealing the vessel opening to seal the dispersion in the vessel.
34. A small-scale mill for milling a pharmaceutical product contained in a dispersion containing attrition milling media, comprising:
a shaft mount; a rotatable shaft mounted for rotation about the shaft mount; a relatively small vessel having an opening; an agitator having a rotor and a rotor shaft extending from the rotor, the shaft being connected to the rotatable shaft and the rotor being dimensioned to be inserted in the vessel with a small gap formed between an outer rotating surface of the rotor and an internal surface of the vessel; a coupling detachably connecting the vessel to the shaft mount, the coupling having an opening through which the rotor shaft extends, wherein the shaft mount sealing the vessel opening to seal the dispersion in the vessel.
31. A small-scale mill for milling a non-soluble product contained in a dispersion containing polymeric attrition milling media, comprising:
a shaft mount; a rotatable shaft mounted for rotation about the shaft mount; a relatively small vessel having an opening; an agitator having a rotor and a rotor shaft extending from the rotor, the shaft being connected to the rotatable shaft and the rotor being dimensioned to be inserted in the vessel with a small gap formed between an outer rotating surface of the rotor and an internal surface of the vessel; a coupling detachably connecting the vessel to the shaft mount, the coupling having an opening through which the rotor shaft extends, wherein the shaft mount sealing the vessel opening to seal the dispersion in the vessel.
36. A small-scale for milling a pharmaceutical product contained in a dispersion containing 500 micron attrition milling media, comprising:
a shaft mount; a rotatable shaft mounted for rotation about the shaft mount; a relatively small vessel having an opening; an agitator having a rotor and a rotor shaft extending from the rotor, the shaft being connected to the rotatable shaft and the rotor being dimensioned to be inserted in the vessel with a small gap no greater than 3 mm formed between an outer rotating surface of the rotor and an internal surface of the vessel; a coupling detachably connecting the vessel to the shaft mount, the coupling having an opening through which the rotator shaft extends, wherein the shaft mount sealing the vessel opening to seal the dispersion in the vessel.
28. A small-scale mill for milling a non-soluble product contained in a dispersion containing 500 micron attrition milling media, comprising:
a shaft mount; a rotatable shaft mounted for rotation about the shaft mount; a relatively small vessel having an opening; an agitator having a rotor and a rotor shaft extending from the rotor, the shaft being connected to the rotatable shaft and the rotor being dimensioned to be inserted in the vessel with a small gap no greater than 3 mm formed between an outer rotating surface of the rotor and an internal surface of the vessel; a coupling detachably connecting the vessel to the shaft mount, the coupling having an opening through which the rotor shaft extends, wherein the shaft mount sealing the vessel opening to seal the dispersion in the vessel.
33. A small-scale for milling a non-soluble product contained in a dispersion containing 500 micron polymeric attrition milling media, comprising:
a shaft mount; a rotatable shaft mounted for rotation about the shaft mount; a relatively small vessel having an opening; an agitator having a rotor and a rotor shaft extending from the rotor, the shaft being connected to the rotatable shaft and the rotor being dimensioned to be inserted in the vessel with a small gap no greater than 3 mm formed between an outer rotating surface of the rotor and an internal surface of the vessel; a coupling detachably connecting the vessel to the shaft mount, the coupling having an opening through which the rotor shaft extends, wherein the shaft mount sealing the vessel opening to seal the dispersion in the vessel.
23. A small-scale mill for milling a non-soluble product contained in a dispersion containing attrition milling media, comprising:
an inner cylindrical wall having a bottom and an open top; an outer cylindrical wall spaced from and surrounding the inner cylindrical wall, the inner and outer cylindrical walls being connected together so that a chamber is formed therebetween; at least first and second passages that communicate with the chamber and adapted to pass coolant; an agitator dimensioned to be inserted in the vessel through the open top; a coupling that closes the open top, the coupling having an opening through which a portion of the agitator extends upwardly; a seal that seals the portion of the agitator while permitting the agitator to rotate; and a motor connected to the portion of the agitator extending through the coupling.
35. A small-scale mill for milling a pharmaceutical product contained in a dispersion containing attrition milling media, comprising:
an inner cylindrical wall having a bottom and an open top; an outer cylindrical wall spaced from and surrounding the inner cylindrical wall, the inner and outer cylindrical walls being connected together so that a chamber is formed therebetween; at least first and second passages that communicate with the chamber and adapted to pass coolant; an agitator dimensioned to be inserted in the vessel through the open top; a coupling that closes the open top, the coupling having an opening through which a portion of the agitator extends upwardly; a seal that seals the portion of the agitator while permitting the agitator to rotate; and a motor connected to the portion of the agitator extending through the coupling.
32. A small-scale mill for milling a non-soluble product contained in a dispersion containing polymeric attrition milling media, comprising:
an inner cylindrical wall having a bottom and an open top; an outer cylindrical wall spaced from and surrounding the inner cylindrical wall, the inner and outer cylindrical walls being connected together so that a chamber is formed therebetween; at least first and second passages that communicate with the chamber and adapted to pass coolant; an agitator dimensioned to be inserted in the vessel through the open top; a coupling that closes the open top, the coupling having an opening through which a portion of the agitator extends upwardly; a seal that seals the portion of the agitator while permitting the agitator to rotate; and a motor connected to the portion of the agitator extending through the coupling.
2. A small-scale mill according to
3. A small scale mill according to
4. A small-scale mill according to
7. A small-scale mill according to
8. A small-scale mill according to
9. A small-scale mill according to
10. A small-scale mill according to
11. A small-scale mill according to
12. A small-scale mill according to
13. A small-scale mill according to
14. A small-scale mill according to
15. A small-scale mill according to
16. A small-scale mill according to
17. A small-scale mill according to
18. A small-scale mill according to
19. A small-scale mill according to
20. A small-scale mill according to
21. A small-scale mill according to
22. A small-scale mill according to
24. A small-scale mill according to
25. A small-scale mill according to
26. A small scale mill according to
27. A small-scale mill according to
29. A small scale mill according to
30. A small-scale mill according to
|
This applications claim priority to U.S. Provisional Application SN. 60/137,142, filed June 1, 1999.
Wet media mills, such as the ones described in U.S. Pat. No. 5,797,550 issued to Woodall, et al, and U.S. Pat. No. 4,848,676 issued to Stehr, are generally used to mill or grind relatively large quantities of materials. These rather large media mills are not generally suitable for grinding small or minute quantities. U.S. Pat. No. 5,593,097 issued to Corbin recognizes the need for milling small quantities, as small as 0.25 grams, to a size less than 0.5 micron to about 0.05 micron in terms of average diameter in about 60 minutes.
The media mill described in the Corbin patent comprises a vertically oriented open top vessel, a vertically extending agitator with pegs, a motor for rotating the agitator, and a controller for controlling the rotational speed. The vessel is a cylindrical centrifuge or test tube formed of a glass, plastic, stainless steel, or other suitable material having an inner diameter of between 10 to 20 mm. The media suitable is described as any non-contaminating, wear resistant material, sized between about 0.17 mm to 1 mm in diameter.
The particulates to be ground and the grinding media are suspended in a dispersion and poured into the vessel. The agitator, with the peg end inserted in the vessel, is spun. The Corbin patent also discloses that the pegs should extend to within between about 1-3 mm of the sides of the vessel to provide the milling desired in the shortest possible time without damaging the materials and producing excessive heat. To avoid splattering created by vortexing of the material during mixing, the top peg of the mixer is positioned even with the top of the dispersion. No seal or cover is deemed needed during mixing or agitation if this practice is followed.
The Corbin patent also discloses that its micro media can be useful for forming medicinal compounds, food additives, catalysts, pigments, and scents. Medicinal or pharmaceutical compounds can be expensive and require much experimentation, with different sizes and quantities. The Corbin patent discloses that the preferred media for medicinal compounds are zirconium oxide and glass. Moreover, pharmaceutical compounds are often heat sensitive, and thus must be maintained at certain temperatures. In this respect, the Corbin patent discloses using a temperature control bath around the vessel.
In the media mill of the type described in the Corbin patent, even if the vessel is filled to the top peg, however, the rotating agitator in the dispersion creates a vortex, which undesirably draws air into the dispersion and foams the dispersion. Moreover, the open top configuration draws in contamination, making the mill unsuitable for pharmaceutical products. The temperature-controlled bath could spill into the open top container and further contaminate the product.
There is a need for a micro or small-scale media mill that avoids these problems. The present invention is believed to meet this need.
The present invention relates to a small-scale or micro media-mill and a method of milling materials, such as pharmaceutical products. The present small-scale mill, which can be vertically or horizontally oriented, can use a dispersion containing attrition milling media and the product to be milled. The milling media can be polymeric type, such as formed of polystyrene or cross-linked polystyrene having a nominal diameter of no greater than 500 microns. Other sizes include 200 microns and 50 microns and a mixture of these sizes.
In one embodiment, the mill has a relatively small vessel having an opening, an agitator, and a coupling, and a rotatable shaft mounted for rotation about a shaft mount. The agitator is dimensioned to be inserted in the vessel through the opening. Specifically, the agitator can have a rotor and a rotor shaft extending from the rotor. The rotor shaft is connected to the rotatable shaft. The rotor is dimensioned to be inserted in the vessel with a small gap formed between an outer rotating surface of the rotor and an internal surface of the vessel. The coupling detachably connects the vessel to the shaft mount. The coupling has an opening through which a portion of the agitator, such as the rotor shaft, extends. The shaft mount seals the vessel opening to seal the dispersion in the vessel. A seal can be provided to seal the portion of the agitator or the rotor shaft while permitting the agitator to rotate. The rotatable shaft can be driven by a motor or can be a motor shaft of a motor, preferably a variable speed motor capable of 6000 RPM.
In one embodiment, the coupling can have a threaded portion for detachably mounting to the shaft mount and a flange portion for detachably coupling to the vessel. In another embodiment, the coupling is integrally formed with the vessel and has a threaded portion for detachably mounting to the shaft mount.
The mill can include a cooling system connected to the vessel. In one embodiment, the cooling system can comprise a water jacket. Specifically, the vessel comprises a cylindrical inner vessel and an outer vessel spaced from and surrounding the inner vessel. The inner and outer vessels form a chamber therebetween. The chamber can be vessel shaped or annular. A flange connects the upper ends of the inner and outer vessel. The outer vessel (acket) has at least first and second passages that communicate with the chamber. The cooling system comprises the outer vessel with the first and second passages, which is adapted to circulate cooling fluid.
In an alternative embodiment, the vessel can comprise an inner cylindrical wall having a bottom and an open top and an outer cylindrical wall spaced from and surrounding the inner vessel. The inner and outer cylindrical walls are connected together so that an annular chamber is formed therebetween. At least the first and second passages are formed at the outer cylindrical wall and communicate with the chamber to pass coolant. The bottom extends radially and covers the bottom end of the outer cylindrical wall. The bottom can have an aperture that allows samples of the dispersion to be withdrawn. A valve can close the aperture. Alternatively, the bottom can have an observation window for observing the dispersion.
In another embodiment, the vessel can include at least one port through which the dispersion is filled. The vessel includes at least two ports through which the dispersion is circulated. In this respect, the cooling system comprises the ports on the vessel for circulating the dispersion. The vessel can be horizontally oriented.
The rotor can be cylindrical, and can have tapered end surfaces. In one embodiment, the rotor is dimensioned so that its outer periphery is spaced no larger than 3 mm away from an inner surface of the vessel, particularly when the dispersion contains attrition media having a nominal size of no larger than 500 microns. The spacing or the gap is preferably no larger than 1 mm, particularly when the dispersion contains attrition media having a nominal size of no larger than 200 microns.
In another embodiment, the cylindrical rotor can have a cavity and a plurality of slots that extend between an inner surface of the cavity and an outer surface of the cylindrical rotor. In another embodiment, the cylindrical rotor can have a plurality of channels extending to an outer surface of the cylindrical rotor. In another embodiment, the cylindrical rotor can have a plurality of passageways extending between the tapered end surfaces of the cylindrical rotor.
One method according to the present invention comprises providing a dispersion containing a non-soluble product to be milled and attrition milling media having a nominal size of no greater than 500 microns; inserting the dispersion into a cylindrical vessel; providing an agitator and a coupling that closes the vessel, the coupling having an opening through which a portion of the agitator extends, the agitator comprising a cylindrical rotor and a shaft extending therefrom, wherein the cylindrical rotor is dimensioned so that an outer periphery is no greater than 3 mm away from an inner surface of the cylindrical wall; inserting an agitator into cylindrical vessel and sealingly closing the coupling, wherein the amount of dispersion inserted into the vessel is so that the dispersion eliminates substantially all of the air in the vessel when the agitator is fully inserted into the vessel; and rotating the agitator for a predetermined period.
Another method according to the present invention comprises providing a dispersion containing a non-soluble product to be milled and attrition milling media having a nominal size of no greater than 500 microns; providing an agitator having a cylindrical rotor and shaft extending therefrom; inserting the agitator in a horizontally oriented cylindrical vessel and sealing the cylindrical vessel, the cylindrical rotor being dimensioned to provide a gap of no greater than 3 mm between an outer surface of the rotor and an inner surface of the vessel; providing at least one port through the cylindrical vessel and maintaining the port at a highest point of the horizontally oriented cylindrical vessel; filling the cylindrical vessel with the dispersion until the dispersion drives out substantially all of the air in the vessel; and rotating the agitator for a predetermined period.
The method further includes cooling the vessel by jacketing the vessel and flowing water between the jacket and the vessel. Another method comprises externally circulating the dispersion through a plurality of ports formed through the horizontally oriented vessel to thereby cool the dispersion or refresh the dispersion.
These and other features, aspects, and advantages of the present invention will become more apparent from the following description, appended claims, and accompanying exemplary embodiments shown in the drawings.
Although references are made below to directions in describing the structure, they are made relative to the drawings (as normally viewed) for convenience. The directions, such as top, bottom, upper, lower, etc., are not intended to be taken literally or limit the present invention.
A small-scale mill 1, 1A, 2 (
A vertically oriented mills 1, 1A is exemplified in
Referring to
The outer cylindrical wall 14 has two openings 20, preferably positioned diametrically opposite to each other and a pair of coolant connectors 22 aligned with the openings 20. Either of these connectors 22 can serve as a coolant inlet or outlet. These connectors 22 can extend substantially radially outwardly. The free end of each connector can have a sanitary fitting, which includes an annular mounting flange 24 and a complementary fitting (essentially mirror image thereof--not shown), adapted to be clamped with, for example, a TRI-CLAMP available from Tri-Clover Inc. of Kenosha, Wis. These mounting flanges 24 are configured substantially similar to the mounting flanges 16, 52 connecting the vessel 10, 10A, 10B, 10C to the motor 100. All of these mounting flanges 16, 24, 52 can be adapted for a TRI-CLAMP, as described below. Each of these flanges 16, 24, 52 has an annular groove G for seating an annular gasket 60 and a beveled or tapered surface B. The mounting flanges and the gasket 60, which is FDA approved, adapted for the TRI-CLAMP are also available from Tri-Clover Inc.
Alternative to the double walled vessel is a single walled vessel 10C shown in
In the embodiments of
The mounting flanges 24 of the connectors 22 (
Referring to the embodiments of
Referring to
The shaft mount 110 has a central through hole 115 dimensioned larger than the shaft 40. The distal (lower) end of the cylindrical member 114 has an annular projection 116 that bears against the seal ring 70 (see
The rotor shaft 40 comprises a larger diameter portion 42 and a smaller diameter portion 44 having a threaded free end 45. A tapered section 46 extends between these portions 42, 44. The rotor 30 is attached to the motor 100 by inserting the smaller diameter portion 44 into a hollow motor shaft 120 and threading a nut 49 or a manual knob 49A (
Although the above-described mill 1 (
Referring to
The vessel 10D is illustrated with four fill/drain/cooling ports P1-P4 for illustrative purposes only. Only one port is needed in the horizontally oriented mill 2. The ports P2-P4 are radially extending through the cylindrical wall 12 of the vessel 10B, whereas the port P1 is axially extending from the end wall 13 of the vessel 10B. In one embodiment, the vessel 10D can have a single top fill port P2 or P3. In such an embodiment, it is especially desirable for the top port P2 or P3 to be located at or along the highest point of the milling chamber, i.e., at 12 O'clock position for a cylindrical vessel 10D, as this allows the chamber to be filled so that all of the air is displaced from the chamber. The absence of air in the milling chamber during operation prevents the formation of foam and enhances milling performance.
Alternatively, the horizontally oriented vessel 10D can contain two or more ports, such as two top radial ports P2 and P3, a single axial port P1 and a single top radial port P3, or a single top radial port P3 and a single bottom radial port P4. In such embodiments, the dispersion can be externally circulated through the vessel 10D, where one port acts as an outlet and the other an inlet. The dispersion can be cooled or replenished during the circulating process. Using two ports, one can recirculate (or add) the process fluid and/or attrition media via an external vessel and pump (not shown). If the attrition media has to remain in the vessel, the outlet port can be fitted with a suitable screen or filter to retain the media during operation.
Referring to
The rotor 32 also can comprise a variety of geometries, surface textures, and surface modifications, such as channels or protrusions to alter the fluid flow patterns. For example, the rotor 32 can be cylindrical (straight), as shown in
Specifically, the hexagonal rotor 32A (
The cylindrical rotors 32G, 32H, 32I, 32J (
The rotors 32G-32J of
In other embodiments (not shown), rotors also can contain pegs, agitator discs, or a combination thereof.
Referring to the cylindrical rotor 32 shown in
The vessel size can vary for milling small amounts of dispersion. Although the present invention is not limited to particular sizes, in the preferred embodiment, the inner diameter of the vessel is between ⅝" inch to 4 inches. By way of examples only, milling chamber of the vessel 10, 10A, 10B, 10C, and 10D and the cylindrical rotor 32 can have the dimensions specified in Tables 1 and 2.
TABLE 1 | |||
(STRAIGHT ROTORS) | |||
CYLINDRICAL VESSEL | |||
Size | #1 | #2 | #3 |
TRI-CLAMP Size | 2" TC | 2.5" TC | 3" TC |
VESSEL/COUPLING | |||
R-vessel (inch) (½ DC) | 0.685 | 0.935 | 1.185 |
H-vessel (inch) (HC) | 1.125 | 1.125 | 1.125 |
R-rotor (inch) (½ DR) | 0.567 | 0.817 | 1.063 |
H-rotor (inch) (HR) | 0.890 | 0.890 | 0.890 |
R-shaft (inch) (½ DS) | 0.313 | 0.313 | 0.313 |
H-shaft (inch) (HS) | 0.118 | 0.118 | 0.118 |
Volume Vessel (in3) | 1.658 | 3.090 | 4.963 |
Volume Rotor (in3) | 0.899 | 1.866 | 3.156 |
Volume Shaft (in3) | 0.036 | 0.036 | 0.036 |
Working Volume (in3) | 0.723 | 1.187 | 1.770 |
11.855 ml | 19.458 ml | 29.012 ml | |
Typical Dispersion | 8.299 ml | 13.621 ml | 20.309 ml |
Volume @ 50% media | |||
charge | |||
Typical Dispersion | 5.453 ml | 8.951 ml | 13.346 ml |
Volume @ 90% media | |||
charge | |||
TABLE 1 | |||
(STRAIGHT ROTORS) | |||
CYLINDRICAL VESSEL | |||
Size | #1 | #2 | #3 |
TRI-CLAMP Size | 2" TC | 2.5" TC | 3" TC |
VESSEL/COUPLING | |||
R-vessel (inch) (½ DC) | 0.685 | 0.935 | 1.185 |
H-vessel (inch) (HC) | 1.125 | 1.125 | 1.125 |
R-rotor (inch) (½ DR) | 0.567 | 0.817 | 1.063 |
H-rotor (inch) (HR) | 0.890 | 0.890 | 0.890 |
R-shaft (inch) (½ DS) | 0.313 | 0.313 | 0.313 |
H-shaft (inch) (HS) | 0.118 | 0.118 | 0.118 |
Volume Vessel (in3) | 1.658 | 3.090 | 4.963 |
Volume Rotor (in3) | 0.899 | 1.866 | 3.156 |
Volume Shaft (in3) | 0.036 | 0.036 | 0.036 |
Working Volume (in3) | 0.723 | 1.187 | 1.770 |
11.855 ml | 19.458 ml | 29.012 ml | |
Typical Dispersion | 8.299 ml | 13.621 ml | 20.309 ml |
Volume @ 50% media | |||
charge | |||
Typical Dispersion | 5.453 ml | 8.951 ml | 13.346 ml |
Volume @ 90% media | |||
charge | |||
It was mentioned that the gap X between the rotor 32 and the inner surface 12" of the cylindrical wall 12 should be approximately 6 times the diameter of the attrition milling media. Nonetheless, the vessel and rotor combination can be used with 50, 200, 500 and mixtures of 50/200, 50/500, or 50/200/500 micron media. These milling media also can be used with a gap X of 1 mm. The rotor speed is correlated to the rotor diameter to produce different tip speeds, which are related to the milling action. A too high tip speed can generate much heat and can evaporate the dispersion. A too low tip speed causes inefficient milling.
Tapering the ends of the rotor 32, as illustrated in
U.S. Pat. No. 5,145,684 issued to Liversidge, et al., U.S. Pat. No. 5,518,187 issued to Bruno et al., and U.S. Pat. Nos. 5,718,388 and 5,862,999 issued to Czekai, et al., disclose milling pharmaceutical products using polymeric milling media. These patents further disclose dispersion formulations for a wet media milling. The disclosures of these patents are incorporated herein by reference.
In operation of the vertically oriented mill 1, 1A, an appropriate dispersion formulation containing the milling media and the product to be milled is prepared, which can be prepared according to the aforementioned patents. The dispersion is poured into the vessel 10, 10A, 10B, 10C to a level that would cause the dispersion to fill to the brim or the top face 61 (see
Because the coupling 50 seals the vessel 10, 10A, 10B, 10C, and because only a very small amount of air is trapped in the vessel, vortexing and contamination problems are minimized or avoided. Thus, the mill according to the present invention can prevent the dispersion formulation from foaming. Further, because the vessel is cooled, either by the cooling jacket or by circulating the dispersion, the rotor 32 can be spun faster. Thus, a higher energy can be transferred to the dispersion.
In the operation of the horizontally oriented mill 2, the vessel 10D is first mounted to the shaft mount 110 with either a threaded coupling 16' (as shown in
Because virtually all or substantially all of the air can be displaced in the horizontally oriented mill 2, vortexing and contamination problems are minimized or avoided. Thus, the mill according to the present invention can prevent the dispersion formulation from foaming. Further, because the dispersion can be circulated, where it can be cooled with external cooling system, the rotor can be spun faster and high energy can be transferred to the dispersion. Moreover, the dispersion can be refreshed or made in batches or inspected without having to disassemble the vessel 10D from the shaft mount 110.
The pharmaceutical products herein include those products described in the aforementioned patents incorporated herein by reference and any human or animal ingestable products and cosmetic products.
Given the disclosure of the present invention, one versed in the art would appreciate that there may be other embodiments and modifications within the scope and spirit of the present invention. Accordingly, all modifications attainable by one versed in the art from the present disclosure within the scope and spirit of the present invention are to be included as further embodiments of the present invention. The scope of the present invention accordingly is to be defined as set forth in the appended claims.
Bosch, H. William, Ryde, Tuula, Czekai, David A., Reed, Robert Gary, Ryde, Niels Peter
Patent | Priority | Assignee | Title |
10463673, | Mar 03 2003 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
10471067, | Mar 03 2003 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
10603669, | Apr 16 2015 | NETZSCH-Feinmahltechnik GmbH | Agitator ball mill |
10709713, | May 26 2010 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
11253478, | May 27 2009 | Alkermes Pharma Ireland Limited | Reduction of flake-like aggregation in nanoparticulate active agent compositions |
11717481, | May 27 2009 | Alkermes Pharma Ireland Limited | Reduction of flake-like aggregation in nanoparticulate active agent compositions |
6976647, | Jun 05 2001 | ATHYRIUM OPPORTUNITIES III ACQUISITION LP | System and method for milling materials |
7101576, | Apr 12 2002 | Alkermes Pharma Ireland Limited | Nanoparticulate megestrol formulations |
7276249, | May 24 2002 | ABBOTT LABORATORIES, IRELAND, LIMITED | Nanoparticulate fibrate formulations |
7320802, | May 24 2002 | ABBOTT LABORATORIES, IRELAND, LIMITED | Methods of treatment using nanoparticulate fenofibrate compositions |
7390505, | Jan 31 2003 | Alkermes Pharma Ireland Limited | Nanoparticulate topiramate formulations |
7459283, | Feb 04 2002 | Alkermes Pharma Ireland Limited | Nanoparticulate compositions having lysozyme as a surface stabilizer |
7713551, | Sep 11 2002 | Alkermes Pharma Ireland Limited | Gel stabilized nanoparticulate active agent compositions |
7763278, | Jun 10 2002 | Alkermes Pharma Ireland Limited | Nanoparticulate polycosanol formulations and novel polycosanol combinations |
7825087, | Apr 13 2005 | Elan Pharma International Limited | Nanoparticulate and controlled release compositions comprising cyclosporine |
7842232, | May 22 2003 | Alkermes Pharma Ireland Limited | Sterilization of dispersions of nanoparticulate active agents with gamma radiation |
7879360, | Nov 05 2003 | Alkermes Pharma Ireland Limited | Nanoparticulate compositions having a peptide as a surface stabilizer |
7910577, | Nov 16 2004 | Alkermes Pharma Ireland Limited | Injectable nanoparticulate olanzapine formulations |
7927627, | May 24 2002 | ABBOTT LABORATORIES, IRELAND, LIMITED | Nanoparticulate fibrate formulations |
7931917, | May 24 2002 | ABBOTT LABORATORIES, IRELAND, LIMITED | Nanoparticulate fibrate formulations |
7998507, | Sep 21 2000 | Alkermes Pharma Ireland Limited | Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors |
8003127, | Mar 23 2005 | Alkermes Pharma Ireland Limited | Nanoparticulate corticosteroid and antihistamine formulations methods of making, and methods of administering thereof |
8119163, | Nov 02 1998 | Alkermes Pharma Ireland Limited | Nanoparticulate and controlled release compositions comprising cefditoren |
8158153, | Mar 17 2005 | Alkermes Pharma Ireland Limited | Nanoparticulate bisphosphonate compositions |
8236352, | Oct 01 1998 | Alkermes Pharma Ireland Limited | Glipizide compositions |
8309133, | Apr 12 2005 | Alkermes Pharma Ireland Limited | Nanoparticulate quinazoline derivative formulations |
8323641, | Feb 04 2002 | Alkermes Pharma Ireland Limited | Nanoparticulate compositions having lysozyme as a surface stabilizer |
8367112, | Feb 28 2006 | Alkermes Pharma Ireland Limited | Nanoparticulate carverdilol formulations |
8512727, | Mar 03 2003 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
8512979, | Apr 12 2005 | SUSTAINABLE TECHNOLOGY CORPORATION | System and process for biomass treatment |
8652464, | Feb 04 2002 | BAUDAX BIO, INC | Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer |
8833688, | Aug 02 2003 | STEPHAN MACHINERY GMBH | Mixing shaft for thorough mixing and comminuting of food products |
9012511, | May 19 2010 | Alkermes Pharma Ireland Limited | Nanoparticulate cinacalcet compositions |
9040088, | Apr 12 2002 | Alkermes Pharma Ireland Limited | Nanoparticulate megestrol formulations |
9044396, | Apr 12 2002 | Alkermes Pharma Ireland Limited | Nanoparticulate megestrol formulations |
9101540, | Apr 12 2002 | Alkermes Pharma Ireland Limited | Nanoparticulate megestrol formulations |
9101549, | Apr 12 2002 | Alkermes Pharma Ireland Limited | Nanoparticulate megestrol formulations |
9107827, | Apr 12 2002 | Alkermes Pharma Ireland Limited | Nanoparticulate megestrol formulations |
9345665, | May 27 2009 | Alkermes Pharma Ireland Limited | Reduction of flake-like aggregation in nanoparticulate active agent compositions |
9410630, | May 06 2013 | Taylor Innovations LLC | Sealing member for use in non-simmering clean service relief valve |
9974746, | May 27 2009 | Alkermes Pharma Ireland Limited | Reduction of flake-like aggregation in nanoparticulate active agent compositions |
9974747, | May 27 2009 | Alkermes Pharma Ireland Limited | Reduction of flake-like aggregation in nanoparticulate active agent compositions |
9974748, | May 27 2009 | Alkermes Pharma Ireland Limited | Reduction of flake-like aggregation in nanoparticulate active agent compositions |
Patent | Priority | Assignee | Title |
5133506, | Mar 07 1990 | Sala International AB | Apparatus for grinding mineral products |
5183215, | Dec 03 1987 | Grinding appliance | |
5464163, | Mar 06 1993 | ZOZ Maschinenbau GmbH | Attritor |
5718388, | May 25 1994 | Alkermes Pharma Ireland Limited | Continuous method of grinding pharmaceutical substances |
EP483808, | |||
EP686428, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
May 31 2000 | Elan Pharma International Limited | (assignment on the face of the patent) | / | |||
Sep 29 2000 | REED, ROBERT GARY | Elan Pharma International Limited | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 011211 | /0761 | |
Sep 29 2000 | RYDE, NIELS PETER | Elan Pharma International Limited | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 011211 | /0761 | |
Sep 29 2000 | BOSCH, H WILLIAM | Elan Pharma International Limited | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 011211 | /0761 | |
Oct 02 2000 | CZEKAI, DAVID A | Elan Pharma International Limited | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 011211 | /0761 | |
Oct 02 2000 | RYDE, TUULA | Elan Pharma International Limited | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 011211 | /0761 | |
Mar 21 2002 | CZEKAI, DAVID A | Elan Pharma International Limited | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 012782 | /0406 | |
Mar 21 2002 | BOSCH, HENRY WILLIAM | Elan Pharma International Limited | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 012782 | /0406 | |
Mar 21 2002 | RYDE, NIELS-PETER MOESGAARD | Elan Pharma International Limited | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 012782 | /0406 | |
Mar 26 2002 | REED, ROBERT GARY | Elan Pharma International Limited | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 012782 | /0406 | |
Aug 02 2011 | Elan Pharma International Limited | EDT PHARMA HOLDINGS LIMITED | ASSET TRANSFER AGREEMENT | 029066 | /0655 | |
Sep 14 2011 | EDT PHARMA HOLDINGS LIMITED | Alkermes Pharma Ireland Limited | CHANGE OF NAME SEE DOCUMENT FOR DETAILS | 029064 | /0645 | |
Sep 16 2011 | Alkermes Pharma Ireland Limited | MORGAN STANLEY SENIOR FUNDING, INC | PATENT SECURITY AGREEMENT FIRST LIEN | 026994 | /0186 | |
Sep 16 2011 | Alkermes Pharma Ireland Limited | MORGAN STANLEY SENIOR FUNDING, INC | PATENT SECURITY AGREEMENT SECOND LIEN | 026994 | /0245 | |
Sep 16 2011 | ALKERMES, INC | MORGAN STANLEY SENIOR FUNDING, INC | PATENT SECURITY AGREEMENT SECOND LIEN | 026994 | /0245 | |
Sep 16 2011 | ALKERMES CONTROLLED THERAPEUTICS INC | MORGAN STANLEY SENIOR FUNDING, INC | PATENT SECURITY AGREEMENT FIRST LIEN | 026994 | /0186 | |
Sep 16 2011 | ALKERMES, INC | MORGAN STANLEY SENIOR FUNDING, INC | PATENT SECURITY AGREEMENT FIRST LIEN | 026994 | /0186 | |
Sep 16 2011 | ALKERMES CONTROLLED THERAPEUTICS INC | MORGAN STANLEY SENIOR FUNDING, INC | PATENT SECURITY AGREEMENT SECOND LIEN | 026994 | /0245 | |
Sep 24 2012 | MORGAN STANLEY SENIOR FUNDING, INC | ALKERMES, INC | RELEASE BY SECURED PARTY SECOND LIEN | 029116 | /0379 | |
Sep 24 2012 | MORGAN STANLEY SENIOR FUNDING, INC | Alkermes Pharma Ireland Limited | RELEASE BY SECURED PARTY SECOND LIEN | 029116 | /0379 | |
Sep 24 2012 | MORGAN STANLEY SENIOR FUNDING, INC | ALKERMES CONTROLLED THERAPEUTICS INC | RELEASE BY SECURED PARTY SECOND LIEN | 029116 | /0379 | |
Nov 17 2017 | Recro Gainesville LLC | ATHYRIUM OPPORTUNITIES III ACQUISITION LP | CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY S NAME PREVIOUSLY RECORDED AT REEL: 044165 FRAME: 0783 ASSIGNOR S HEREBY CONFIRMS THE GRANT OF SECURITY INTEREST | 048540 | /0737 | |
Nov 17 2017 | Recro Gainesville LLC | ATHYRIUM OPPORTUNITIES III ACQUSITION LP | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 044165 | /0783 | |
Dec 16 2022 | ATHYRIUM OPPORTUNITIES III ACQUISITION LP | SOCIETAL CDMO GAINESVILLE, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 062123 | /0339 |
Date | Maintenance Fee Events |
Feb 13 2006 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Feb 16 2010 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Feb 13 2014 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
Aug 13 2005 | 4 years fee payment window open |
Feb 13 2006 | 6 months grace period start (w surcharge) |
Aug 13 2006 | patent expiry (for year 4) |
Aug 13 2008 | 2 years to revive unintentionally abandoned end. (for year 4) |
Aug 13 2009 | 8 years fee payment window open |
Feb 13 2010 | 6 months grace period start (w surcharge) |
Aug 13 2010 | patent expiry (for year 8) |
Aug 13 2012 | 2 years to revive unintentionally abandoned end. (for year 8) |
Aug 13 2013 | 12 years fee payment window open |
Feb 13 2014 | 6 months grace period start (w surcharge) |
Aug 13 2014 | patent expiry (for year 12) |
Aug 13 2016 | 2 years to revive unintentionally abandoned end. (for year 12) |